Amicus Therapeutics is a
prestigious company university
established in 2002 in United States. It is represented
by 6 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Natural Sciences (2 scientists), Medical and Health Sciences (1 scientists), and Engineering & Technology (0 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 1
Huntington's disease
rare disease
Fabry disease
Pompe disease
Lysosomal disorders
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
13
0.591
* Total H Index Rankings
Ranking Based
On Selection: 2
Neuroscience
Neurodevelopment
Neurodegeneration
Myelination
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
* Total H Index Rankings
Ranking Based
On Selection: 3
Health Economics & Outcomes Research
RWE
Pharmacoepidemiology
Health Economics
PROs
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Joseph Giuliano
Amicus Therapeutics
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
13
0.591
Huntington's disease
rare disease
Fabry disease
Pompe disease
Lysosomal disorders
Biliana Veleva Rotse
Amicus Therapeutics
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
5
5
1.000
Syed Raza|S Raza, Syed I.Raza, SI. Raza
Amicus Therapeutics
Philadelphia, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
3
3
1.000
Health Economics & Outcomes Research
RWE
Pharmacoepidemiology
Health Economics
PROs